首页> 外国专利> Rapid, direct, and qualitative method for the determination of the number of HIV-1-infected patient cells employing reactive oxygen intermediate generators

Rapid, direct, and qualitative method for the determination of the number of HIV-1-infected patient cells employing reactive oxygen intermediate generators

机译:快速,直接,定性的方法使用活性氧中间生成器确定HIV-1感染的患者细胞的数量

摘要

The ability to monitor the progression of human immunodeficiency virus (HIV) infection in patients is paramount to the study of HIV transmission, in predicting the onset and advancement of disease, and evaluating the clinical efficacy of therapeutics. Present methods available to the clinician for the study of HIV pathogenesis employ surrogate markers. Surrogate markers are biological indicators that tend to reflect, to varying extent, the gradual progression of the asymptomatic state to the development of acquired immune deficiency syndrome (AIDS). The most commonly used markers are CD4.sup.+ lymphocyte counts and HIV p24 antigen production. The use of markers to evaluate disease progression suffers from a number of limitations. No known marker consistently reflects disease progression in all patients and stages of disease. Moreover, an effective marker must rapidly reflect the changes associated with antiviral therapy. Accordingly, there still exists in the field a need for a rapid and direct technique for assessing the viral load of an HIV- infected patient. The present invention discloses a rapid method for qualitatively determining the number of HIV-1-infected patient cells in a sample. Patient cells are subjected to direct stimulation with reactive oxygen intermediate generator(s), in the absence of co-culture with donor cells, and the quantity of p24 antigen produced from said stimulation ascertained. These values are compared to those values obtained from HIV- 1 chronically infected cell lines of known proviral copy number (e.g., ACH-2 and U1.1) and the number of infected patient cells determined. This method provides a facile, rapid, and direct method for the assessment of viral load.
机译:监测患者中人类免疫缺陷病毒(HIV)感染进展的能力对于研究HIV传播,预测疾病的发作和进展以及评估治疗剂的临床疗效至关重要。临床医生可用于研究HIV发病机理的现有方法采用了替代标记。替代标志物是一种生物学指标,倾向于在不同程度上反映出无症状状态向获得性免疫缺陷综合症(AIDS)发展的过程。最常用的标记是CD4 +淋巴细胞计数和HIV p24抗原产生。使用标记物评估疾病进展受到许多限制。没有已知的标记能够始终如一地反映所有患者和疾病阶段的疾病进展。此外,有效的标记物必须迅速反映与抗病毒治疗相关的变化。因此,在该领域中仍然需要用于评估HIV感染患者的病毒载量的快速且直接的技术。本发明公开了一种定性确定样品中HIV-1感染患者细胞数量的快速方法。在不与供体细胞共培养的情况下,用一种或多种活性氧中间产生剂对患者细胞进行直接刺激,并确定由所述刺激产生的p24抗原的量。将这些值与从已知原病毒拷贝数(例如ACH-2和U1.1)的HIV-1慢性感染细胞系获得的值进行比较,并确定感染患者细胞的数量。这种方法提供了一种简便,快速,直接的方法来评估病毒载量。

著录项

  • 公开/公告号US5667964A

    专利类型

  • 公开/公告日1997-09-16

    原文格式PDF

  • 申请/专利权人 CORNELL RESEARCH FOUNDATION INC.;

    申请/专利号US19940331218

  • 发明设计人 JOHN LAP HO;

    申请日1994-10-28

  • 分类号C12Q1/70;C12Q1/00;

  • 国家 US

  • 入库时间 2022-08-22 03:09:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号